Monday, February 26, 2007
Surface Logix Inc
From obesity to cardiovascular segments, Surface Logix applies a unique approach for drug development by using nanotechnology. Hear from the CEO on the programs and vision for the future.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment